Randomised phase II trial of olaparib, chemotherapy or olaparib and cediranib in patients with platinum-resistant ovarian cancer (OCTOVA): a study protocol.
Anita MansouriNaomi McGregorRachel DunnSam DobbieJane HolmesLinda CollinsShibani NicumPublished in: BMJ open (2021)
ISRCTN: ISRCTN14784018, clinicaltrials.gov: NCT03117933; Pre-results.